Published in Lancet on January 18, 1997
The Rotterdam Study: objectives and design update. Eur J Epidemiol (2007) 5.78
Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ (2001) 5.40
Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol (2005) 5.30
Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc Natl Acad Sci U S A (1998) 4.49
Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors. Lancet Neurol (2008) 4.14
Aggregation of vascular risk factors and risk of incident Alzheimer disease. Neurology (2005) 4.04
Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo. Proc Natl Acad Sci U S A (2001) 3.50
The Rotterdam Study: 2010 objectives and design update. Eur J Epidemiol (2009) 3.44
The Rotterdam Study: 2012 objectives and design update. Eur J Epidemiol (2011) 3.26
Vascular risk factors and dementia: how to move forward? Neurology (2009) 2.97
Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease. Acta Neuropathol (2009) 2.85
Androgen Deprivation Therapy and Future Alzheimer's Disease Risk. J Clin Oncol (2015) 2.71
The Rotterdam Study: 2014 objectives and design update. Eur J Epidemiol (2013) 2.56
The protocols for the 10/66 dementia research group population-based research programme. BMC Public Health (2007) 2.54
Fibrinogen and beta-amyloid association alters thrombosis and fibrinolysis: a possible contributing factor to Alzheimer's disease. Neuron (2010) 2.37
Adverse oral health and cognitive decline: the health, aging and body composition study. J Am Geriatr Soc (2013) 2.27
Vascular risk factors, cognitive decline, and dementia. Vasc Health Risk Manag (2008) 2.13
MRI predictors of cognition in subcortical ischemic vascular disease and Alzheimer's disease. Neurology (2001) 2.11
Effect of infarcts on dementia in the Baltimore longitudinal study of aging. Ann Neurol (2008) 2.10
Biomarkers of Alzheimer disease in plasma. NeuroRx (2004) 2.02
Coronary artery disease is associated with Alzheimer disease neuropathology in APOE4 carriers. Neurology (2006) 1.89
The Alzheimer's disease beta-secretase enzyme, BACE1. Mol Neurodegener (2007) 1.81
Neurovascular dysfunction, inflammation and endothelial activation: implications for the pathogenesis of Alzheimer's disease. J Neuroinflammation (2011) 1.68
The Rotterdam Study: 2016 objectives and design update. Eur J Epidemiol (2015) 1.61
Cardiovascular risk factors promote brain hypoperfusion leading to cognitive decline and dementia. Cardiovasc Psychiatry Neurol (2012) 1.57
Heart failure and Alzheimer's disease. J Intern Med (2014) 1.54
Oleuropein in olive and its pharmacological effects. Sci Pharm (2010) 1.53
Midlife stroke risk and cognitive decline: a 10-year follow-up of the Whitehall II cohort study. Alzheimers Dement (2012) 1.45
Ventricular dilation: association with gait and cognition. Ann Neurol (2009) 1.45
Vascular basis for brain degeneration: faltering controls and risk factors for dementia. Nutr Rev (2010) 1.44
Cognitive function in the oldest old: women perform better than men. J Neurol Neurosurg Psychiatry (2001) 1.44
New therapeutic targets in the neurovascular pathway in Alzheimer's disease. Neurotherapeutics (2008) 1.44
The relationship between Helicobacter pylori infection and Alzheimer's disease in Japan. J Neurol (2011) 1.44
Alzheimer's disease and mild cognitive impairment. Neurol Clin (2007) 1.39
Neuropsychological contributions to the early identification of Alzheimer's disease. Neuropsychol Rev (2008) 1.35
Atherosclerosis, dementia, and Alzheimer disease in the Baltimore Longitudinal Study of Aging cohort. Ann Neurol (2010) 1.32
Imaging in population science: cardiovascular magnetic resonance in 100,000 participants of UK Biobank - rationale, challenges and approaches. J Cardiovasc Magn Reson (2013) 1.31
Dementia and its implications for public health. Prev Chronic Dis (2006) 1.30
Risk and protective effects of the APOE gene towards Alzheimer's disease in the Kungsholmen project: variation by age and sex. J Neurol Neurosurg Psychiatry (2004) 1.25
The treatment of hyperhomocysteinemia. Annu Rev Med (2009) 1.23
Amyloid-β as a modulator of synaptic plasticity. J Alzheimers Dis (2010) 1.22
Alzheimer disease therapy: can the amyloid cascade be halted? J Clin Invest (2003) 1.19
Smoking, drinking, and incident cognitive impairment: a cohort community based study included in the Gospel Oak project. J Neurol Neurosurg Psychiatry (2000) 1.19
Heart failure and cognitive impairment: challenges and opportunities. Clin Interv Aging (2007) 1.18
Association of aortic atherosclerosis with cerebral beta-amyloidosis and learning deficits in a mouse model of Alzheimer's disease. Am J Pathol (2003) 1.14
Altered diastolic function and aortic stiffness in Alzheimer's disease. Clin Interv Aging (2014) 1.14
The effects of cardiovascular risk factors on cognitive compromise. Dialogues Clin Neurosci (2009) 1.13
Blood-based biomarkers of microvascular pathology in Alzheimer's disease. Exp Gerontol (2009) 1.12
Alterations of the sphingolipid pathway in Alzheimer's disease: new biomarkers and treatment targets? Neuromolecular Med (2010) 1.12
Cerebrovascular lesions induce transient β-amyloid deposition. Brain (2011) 1.10
Morphological and pathological evolution of the brain microcirculation in aging and Alzheimer's disease. PLoS One (2012) 1.09
Cerebral emboli as a potential cause of Alzheimer's disease and vascular dementia: case-control study. BMJ (2006) 1.09
Elevated abeta42 in skeletal muscle of Alzheimer disease patients suggests peripheral alterations of AbetaPP metabolism. Am J Pathol (2000) 1.09
Reduced risk of Alzheimer's disease with high folate intake: the Baltimore Longitudinal Study of Aging. Alzheimers Dement (2005) 1.07
Microvessels from Alzheimer's disease brains kill neurons in vitro. Am J Pathol (1999) 1.06
An association analysis of Alzheimer disease candidate genes detects an ancestral risk haplotype clade in ACE and putative multilocus association between ACE, A2M, and LRRTM3. Am J Med Genet B Neuropsychiatr Genet (2009) 1.05
Evidence of endothelial dysfunction in the development of Alzheimer's disease: Is Alzheimer's a vascular disorder? Am J Cardiovasc Dis (2013) 1.05
Failure to detect Chlamydia pneumoniae in brain sections of Alzheimer's disease patients. J Clin Microbiol (2000) 1.04
Treatment of cardiovascular risk factors to prevent cognitive decline and dementia: a systematic review. Vasc Health Risk Manag (2010) 1.04
A population study of apoE genotype at the age of 85: relation to dementia, cerebrovascular disease, and mortality. J Neurol Neurosurg Psychiatry (1998) 1.02
Risk factors for vascular dementia: hypotension as a key point. Vasc Health Risk Manag (2008) 1.02
Relation of cerebral vessel disease to Alzheimer's disease dementia and cognitive function in elderly people: a cross-sectional study. Lancet Neurol (2016) 1.02
Repurposing diabetes drugs for brain insulin resistance in Alzheimer disease. Diabetes (2014) 1.01
Caffeine protects against disruptions of the blood-brain barrier in animal models of Alzheimer's and Parkinson's diseases. J Alzheimers Dis (2010) 1.01
The APOE ɛ4/ɛ4 genotype potentiates vascular fibrin(ogen) deposition in amyloid-laden vessels in the brains of Alzheimer's disease patients. J Cereb Blood Flow Metab (2013) 1.01
The cross-sectional relationship between body mass index, waist-hip ratio, and cognitive performance in postmenopausal women enrolled in the Women's Health Initiative. J Am Geriatr Soc (2010) 1.01
Apolipoprotein E4 is only a weak predictor of dementia and cognitive decline in the general population. J Med Genet (2002) 1.00
Cardiovascular risk factors and future risk of Alzheimer's disease. BMC Med (2014) 1.00
Global epidemiology of dementia: Alzheimer's and vascular types. Biomed Res Int (2014) 0.99
Cardiovascular disease and cognitive decline in postmenopausal women: results from the Women's Health Initiative Memory Study. J Am Heart Assoc (2013) 0.99
Familial Alzheimer disease in Latinos: interaction between APOE, stroke, and estrogen replacement. Neurology (2006) 0.98
Neuronutrition and Alzheimer's disease. J Alzheimers Dis (2010) 0.97
HMGCR is a genetic modifier for risk, age of onset and MCI conversion to Alzheimer's disease in a three cohorts study. Mol Psychiatry (2014) 0.95
Blood pressure and dementia - a comprehensive review. Ther Adv Neurol Disord (2009) 0.95
Type 2 diabetes and ethnic disparities in cognitive impairment. Ethn Dis (2012) 0.95
Nonstroke cardiovascular disease and risk of Alzheimer disease and dementia. Alzheimer Dis Assoc Disord (2010) 0.95
Vascular aspects of cognitive impairment and dementia. J Cereb Blood Flow Metab (2013) 0.95
Subclinical hyperthyroidism and dementia: the Sao Paulo Ageing & Health Study (SPAH). BMC Public Health (2010) 0.94
Carotid atherosclerosis and prospective risk of dementia. Stroke (2012) 0.93
Age-related influence of the HDL receptor SR-BI on synaptic plasticity and cognition. Neurobiol Aging (2007) 0.93
Transcranial doppler ultrasound blood flow velocity and pulsatility index as systemic indicators for Alzheimer's disease. Alzheimers Dement (2011) 0.93
Cardioprotective and neuroprotective roles of oleuropein in olive. Saudi Pharm J (2010) 0.92
Interindividual variation in serum cholesterol is associated with regional white matter tissue integrity in older adults. Hum Brain Mapp (2012) 0.91
The Basic Biology of BACE1: A Key Therapeutic Target for Alzheimer's Disease. Curr Genomics (2007) 0.90
Role of Aβ-receptor for advanced glycation endproducts interaction in oxidative stress and cytosolic phospholipase A₂ activation in astrocytes and cerebral endothelial cells. Neuroscience (2011) 0.89
Insulin resistance in Alzheimer's disease. Neurobiol Dis (2014) 0.88
Serum lipids are related to Alzheimer's pathology in nursing home residents. Dement Geriatr Cogn Disord (2009) 0.87
Cardiovascular damage in Alzheimer disease: autopsy findings from the Bryan ADRC. J Biomed Biotechnol (2005) 0.87
Cerebrovascular disease in ageing and Alzheimer's disease. Acta Neuropathol (2015) 0.87
Mid-life proteinuria and late-life cognitive function and dementia in elderly men: the Honolulu-Asia Aging Study. Alzheimer Dis Assoc Disord (2015) 0.87
Human isoprenoid synthase enzymes as therapeutic targets. Front Chem (2014) 0.86
Lipoprotein(a), apolipoprotein E genotype, and risk of Alzheimer's disease. J Neurol Neurosurg Psychiatry (2002) 0.86
Testosterone deficiency accelerates neuronal and vascular aging of SAMP8 mice: protective role of eNOS and SIRT1. PLoS One (2012) 0.86
Atlas-derived perfusion correlates of white matter hyperintensities in patients with reduced cardiac output. Neurobiol Aging (2009) 0.85
Influence of carotid artery stenting on cognitive function. Neuroradiology (2010) 0.85
Long term changes in phospho-APP and tau aggregation in the 3xTg-AD mice following cerebral ischemia. Neurosci Lett (2011) 0.85
Monoamine oxidase enzymes and oxidative stress in the rat optic nerve: age-related changes. Int J Exp Pathol (2012) 0.84
The Cache County Study on Memory in Aging: factors affecting risk of Alzheimer's disease and its progression after onset. Int Rev Psychiatry (2013) 0.84
Impaired Aβ clearance: a potential link between atherosclerosis and Alzheimer's disease. Front Aging Neurosci (2015) 0.84
Decreased vasomotor reactivity in Alzheimer's disease. J Clin Neurol (2007) 0.83
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. N Engl J Med (2001) 7.85
Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol (1991) 7.67
Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology (1999) 7.55
Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation (1997) 7.03
De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am J Hum Genet (2001) 5.61
Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann Neurol (2000) 5.34
Diuretics, beta-blockers, and the risk for sudden cardiac death in hypertensive patients. Ann Intern Med (1995) 5.12
The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology (1995) 5.08
Cardiovascular mortality in Dutch men during 1996 European football championship: longitudinal population study. BMJ (2001) 4.87
Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry (2001) 4.51
The epidemiology of heart failure. Eur Heart J (1997) 4.31
Association between arterial stiffness and atherosclerosis: the Rotterdam Study. Stroke (2001) 3.99
Early outcome after off-pump versus on-pump coronary bypass surgery: results from a randomized study. Circulation (2001) 3.96
J-shaped relation between change in diastolic blood pressure and progression of aortic atherosclerosis. Lancet (1994) 3.95
Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European Studies of Dementia. Neurology (1999) 3.95
Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions. Nat Genet (2001) 3.82
Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology (1994) 3.75
The prevalence of dementia in Europe: a collaborative study of 1980-1990 findings. Eurodem Prevalence Research Group. Int J Epidemiol (1991) 3.70
J-shaped relation between blood pressure and stroke in treated hypertensives. Hypertension (1999) 3.51
External validation is necessary in prediction research: a clinical example. J Clin Epidemiol (2003) 3.49
Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam study. BMJ (1995) 3.42
Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology (2000) 3.39
Peripheral arterial disease in the elderly: The Rotterdam Study. Arterioscler Thromb Vasc Biol (1998) 3.37
The prevalence of primary open-angle glaucoma in a population-based study in The Netherlands. The Rotterdam Study. Ophthalmology (1994) 3.30
Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study. Lancet (1998) 3.26
Prevalence of heart failure and left ventricular dysfunction in the general population; The Rotterdam Study. Eur Heart J (1999) 3.18
Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease. J Neurol Neurosurg Psychiatry (1997) 3.14
The prognosis of heart failure in the general population: The Rotterdam Study. Eur Heart J (2001) 3.07
Effect size estimates of lifestyle and dietary changes on all-cause mortality in coronary artery disease patients: a systematic review. Circulation (2005) 2.99
Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy. Epilepsia (1997) 2.82
Genetic association of apolipoprotein E with age-related macular degeneration. Am J Hum Genet (1998) 2.82
Age-related macular degeneration and smoking. The Rotterdam Study. Arch Ophthalmol (1996) 2.80
Cerebral white matter lesions and subjective cognitive dysfunction: the Rotterdam Scan Study. Neurology (2001) 2.80
Genetic linkage studies suggest that Alzheimer's disease is not a single homogeneous disorder. Nature (1990) 2.80
Atrial fibrillation and dementia in a population-based study. The Rotterdam Study. Stroke (1997) 2.79
Time scale dependent viscoelastic and contractile regimes in fibroblasts probed by microplate manipulation. J Cell Sci (1997) 2.73
Bone density in non-insulin-dependent diabetes mellitus. The Rotterdam Study. Ann Intern Med (1995) 2.70
Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann Neurol (1997) 2.67
Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nat Genet (1994) 2.65
Cardiovascular disease and distribution of cognitive function in elderly people: the Rotterdam Study. BMJ (1994) 2.60
Germline mosaicism and Duchenne muscular dystrophy mutations. Nature (1987) 2.56
Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study. Arch Neurol (1998) 2.53
Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophy from 1950 to 1989. N Engl J Med (1999) 2.53
Is carotid intima-media thickness useful in cardiovascular disease risk assessment? The Rotterdam Study. Stroke (2001) 2.49
Dietary antioxidants and cognitive function in a population-based sample of older persons. The Rotterdam Study. Am J Epidemiol (1996) 2.45
A polymorphism in the glucocorticoid receptor gene may be associated with and increased sensitivity to glucocorticoids in vivo. J Clin Endocrinol Metab (1998) 2.45
Prevalence of Parkinson's disease in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology (2000) 2.45
Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology (2000) 2.43
Third generation oral contraceptives and risk of venous thrombosis: meta-analysis. BMJ (2001) 2.43
Primary open-angle glaucoma, intraocular pressure, and systemic blood pressure in the general elderly population. The Rotterdam Study. Ophthalmology (1995) 2.43
NSAIDs and incident Alzheimer's disease. The Rotterdam Study. Neurobiol Aging (1999) 2.41
Estimation of the mutation frequencies in Charcot-Marie-Tooth disease type 1 and hereditary neuropathy with liability to pressure palsies: a European collaborative study. Eur J Hum Genet (1996) 2.40
Does drug treatment improve survival? Reconciling the trials in mild-to-moderate hypertension. J Hypertens (1995) 2.40
Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein gene. Nat Genet (1992) 2.40
Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men. J Clin Endocrinol Metab (2000) 2.36
Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity. J Intern Med (2001) 2.35
Comparison between measures of atherosclerosis and risk of stroke: the Rotterdam Study. Stroke (2003) 2.31
APOE and Alzheimer disease: a major gene with semi-dominant inheritance. Mol Psychiatry (2011) 2.31
Circle of Willis: morphologic variation on three-dimensional time-of-flight MR angiograms. Radiology (1998) 2.30
Prevalence of Parkinson's disease in the elderly: the Rotterdam Study. Neurology (1995) 2.30
Limitations of sensitivity, specificity, likelihood ratio, and bayes' theorem in assessing diagnostic probabilities: a clinical example. Epidemiology (1997) 2.28
Molecular biological characterization of an azole-resistant Candida glabrata isolate. Antimicrob Agents Chemother (1997) 2.27
Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease. Hum Mol Genet (1998) 2.26
Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology. Mol Psychiatry (2013) 2.25
Carotid intima-media thickness at different sites: relation to incident myocardial infarction; The Rotterdam Study. Eur Heart J (2002) 2.22
Incidence, risk, and case fatality of first ever stroke in the elderly population. The Rotterdam Study. J Neurol Neurosurg Psychiatry (2003) 2.18
QTc dispersion predicts cardiac mortality in the elderly: the Rotterdam Study. Circulation (1998) 2.15
Genetic contribution of FUS to frontotemporal lobar degeneration. Neurology (2010) 2.14
Cognitive correlates of ventricular enlargement and cerebral white matter lesions on magnetic resonance imaging. The Rotterdam Study. Stroke (1994) 2.14
Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies. EURODEM Incidence Research Group. Neurology (1999) 2.13
Postprandial triglyceride response in young adult men and familial risk for coronary atherosclerosis. Ann Intern Med (1994) 2.11
Preoperative prediction of severe postoperative pain. Pain (2003) 2.11